Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Biofeedback In The Treatment Of Blepharospasm: A Case Study.

G. E. Rowan, K. Sedlacek
Published 1981 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Although biofeedback has been of value in treating spastic paresis and torticollis, its effectiveness in other movement disorders is less clear. Blepharospasm, which has no definitive treatment, often has a strong psychogenic component. The authors report the use of electromyographic and temperature biofeedback in a women with blepharospasm who had responded poorly to psychotherapy. Her improvement during biofeedback treatment further elucidated psychogenic factors contributing to the disorder. At 3-months follow-up it seemed that the patient's secondary gain from the blepharospasm diminished the maximum treatment response she could have had to biofeedback.
This paper references



This paper is referenced by
Botulinum toxin type A therapy for blepharospasm (Review)
J. Costa (2009)
10.1007/BF01000752
Blepharospasm: A case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback
P. Brantley (1985)
10.1016/0002-9394(84)90184-3
Biofeedback therapy of essential blepharospasm.
R. Surwit (1984)
10.1002/mds.22608
Paramedical treatment in primary dystonia: A systematic review
Cathérine C.S. Delnooz (2009)
10.1016/0146-6402(83)90018-8
The behavioural management of tic disorders: A critical review
G. Turpin (1983)
10.1007/978-3-319-46062-8_4
Rehabilitation of Dystonia
D. Dressler (2017)
10.5631/JIBIRINSUPPL1986.1993.SUPPLEMENT66_43
Hemifacial Spasm; EMG-Histogram Evaluation
H. Saito (1993)
10.1007/s00717-015-0274-5
Dystonien, Therapie mit Botulinum-Toxin und alternative therapeutische Ansätze in der Ophthalmologie
J. Nepp (2015)
10.1016/0022-3999(85)90012-1
Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches.
M. Faulstich (1985)
10.1007/978-3-642-74731-1_17
Verhaltenstherapeutische Behandlungsansätze bei dystonen Syndromen
P. Kosarz (1989)
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
10.1002/14651858.CD004900.PUB2
Botulinum toxin type A therapy for blepharospasm.
J. Costa (2005)
10.1007/S10484-005-8424-1
An Instrument for Biofeedback Applied to Vision
D. Giorgi (2005)
10.1080/00029157.1984.10402586
Hypnosis and biofeedback as adjunctive therapy in blepharospasm: a case report.
J. K. Murphy (1984)
10.1016/0039-6257(83)90195-9
Biofeedback for ophthalmologic disorders.
M. Rotberg (1983)
Semantic Scholar Logo Some data provided by SemanticScholar